Prospects for Investing in 3D Bioprinting Technology in Russia

Student: Veselkova Alexandra

Educational Programme: Health Care Administration and Economics (Master)

Year of Graduation: 2021

3D bioprinting is a promising area of regenerative medicine in the 21st century, the essence of which is to obtain the most imitating “natural” tissues and organs from human cells using various 3D printing technologies.At present, there is a tendency for a shortage of donor organs and an increase in the number of in-need recipients all over the world. There is a need to search for new methods of solving the current situation. One of these most promising solutions is 3D bioprinting.This master’s thesis assesses the investment prospects of 3D bioprinting of artificial organs on the scale of the Russian Federation from the position of a private investor interested in creating a biotechnological laboratory, and also proposes an original business model, where a certain niche is chosen as the leading direction - the liver.

Student Theses at HSE must be completed in accordance with the University Rules and regulations specified by each educational programme.

Summaries of all theses must be published and made freely available on the HSE website.

The full text of a thesis can be published in open access on the HSE website only if the authoring student (copyright holder) agrees, or, if the thesis was written by a team of students, if all the co-authors (copyright holders) agree. After a thesis is published on the HSE website, it obtains the status of an online publication.

Student theses are objects of copyright and their use is subject to limitations in accordance with the Russian Federation’s law on intellectual property.

In the event that a thesis is quoted or otherwise used, reference to the author’s name and the source of quotation is required.

Search all student theses